News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Pfizer Inc. Sues Novartis AG Over Vfend Antifungal Patents
January 7, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - Pfizer Inc (PFE.N) has sued Novartis AG's (NOVN.VX) Sandoz unit, accusing it of infringing its U.S. patents related to the antifungal treatment Vfend.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Pfizer
Novartis
MORE ON THIS TOPIC
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Drug pricing
Trump Administration Reaches Pricing Agreements With 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Policy
Disc Shares Slip Amid Report FDA’s Prasad Is Skeptical of Bitopertin’s Efficacy
December 22, 2025
·
2 min read
·
Nick Paul Taylor
FDA
FDA Policy Tracker: 2025 Was a Year of Change
December 22, 2025
·
13 min read
·
Heather McKenzie
